Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Upper GI
Home
Upper GI
Upper GI
Type here to filter the list
E359: Inhibitor of GSK3β impedes the development of reflux-induced esophageal cancer
Favorite
E360: National Trends in Multimodality Therapy for Gastric Cancer: Increased use of Perioperative Chemotherapy
Favorite
E361: A Decade Experience with Robotic Assisted Trans-Thoracic Esophagectomy
Favorite
E362: Current gastric cancer AJCC staging may overestimate survival of patients with neoadjuvant chemoradiation; analysis of the National Cancer Database 2004-2018
Favorite
E363: Clinical Outcomes Following Multivisceral Resection for Gastric Cancer: Propensity Score Analysis of a Single Center Experience Over Three Decades
Favorite
E364: Correlation of 18F-Fluorodeoxyglucose Positron Emission Tomography Uptake with Pathologic Response in Patients with Gastroesophageal Junction Adenocarcinoma
Favorite
E365: Fragmentation of Gastroesophageal Junction Cancer Care in California
Favorite
E366: Time to first treatment and optimal adjuvant treatment strategy in resectable gastric cancer patients pathologically upstaged to lymph node positive disease
Favorite
E367: The Inaccuracies of Gastric Adenocarcinoma Clinical Staging and its Predictive Factors
Favorite
E368: Neoadjuvant Gastric Score: How Response to Neoadjuvant Chemotherapy Affects Overall Survival and Adjuvant Benefit
Favorite
E369: Helicobacter pylori and Pepsinogen as Biomarkers for Gastric Cancer in Diverse United States Population
Favorite
E370: Duodenal Gastrointestinal Stromal Tumors and Neoadjuvant Tyrosine Kinase Inhibitor Therapy
Favorite
E371: Patient metabolic profiles defined by liver and muscle 18F-FDG PET avidity are independently associated with overall survival in gastric cancer
Favorite
E372: Transhiatal Esophagectomy with Transcervical Endoscopic Esophageal Mobilization is a Minimally Invasive Approach with Favorable Oncologic and Perioperative Outcomes
Favorite
E373: Aggressive Multidisciplinary Management of Gastric Cancer Patients with Malignant Ascites: A Single Institution Experience
Favorite
E374: Contemporary Outcomes for Resected Type 1-3 Gastroesophageal Junction Adenocarcinoma: A Single Center Experience
Favorite
E375: Exploring Cancer-Testis Antigen (CTA) Expression in Gastric Cancer
Favorite
E376: Hispanic patients with early-onset gastric cancer have a unique gene expression profile
Favorite
E380: Surgery for Gastric Cancer: A Three Decade Time Trend Analysis of Clinical, Pathologic, Operative, and Oncologic Outcomes
Favorite
E381: Effects of Tumor Localization, Age, and Stage on the Outcomes of Gastric and Colorectal Signet Ring Cell Adenocarcinomas
Favorite
E382: Minimally Invasive Versus Open Gastrectomy for Gastric Adenocarcinoma
Favorite
GPP22: A Prospective Analysis of 168 Cases of Total Robotic 3-Stage Espophagectomy for Carcinoma Esophagus in a Tertiary Care Cancer Centre
Favorite
GPPO6: The Usefulness of Presepsin as a Diagnostic Marker of Postoperative Infectious Complications after Esophagectomy
Favorite
P76: Surgeon Perspectives on Management of Aborted Cancer Surgery: Results of an SSO Member Survey
Favorite
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Favorite
P78: Pilot Study of a Telehealth Intervention for Self-Management of Eating after Gastroesophageal Cancer Surgery
Favorite
P79: Impact of Tumor Size and Management on Survival in Gastric GIST
Favorite
P80: Accuracy of Clinical Staging for Intramural (T2) Gastric Cancer: Survival Outcomes Following Upfront Surgical Resection Compared to Risk of Overtreatment with Neoadjuvant Therapy
Favorite
P81: Neoadjuvant Chemotherapy for Gastric Cancer in the Elderly: Are We Accomplishing Our Treatment Goals or Should we Consider an Upfront Surgery Approach
Favorite
P82: Short- and Long- Term Outcomes of Minimally Invasive vs Open Gastrectomy after Neoadjuvant Chemotherapy for Gastric cancer.
Favorite
P83: Primary and Metastatic Gastric Cancers in Patient-derived Orthotopic Xenografts Brightly Labeled by Fluorescent anti-CEA Antibody
Favorite
P84: Outcomes After Minimally Invasive Gastrectomy for Locally Advanced Gastric Cancer
Favorite